He replaces interim CEO Barry McBride who reassumes his role as Executive Vice President Gloves, Antiseptics and Global R&D.
GÖTEBORG, Sweden, Nov. 30, 2020 /PRNewswire/ -- Today, Zlatko Rihter assumes his position as President and CEO of Mölnlycke.
He replaces interim CEO Barry McBride who reassumes his role as Executive Vice President Gloves, Antiseptics and Global R&D.
Zlatko Rihter has extensive experience from the healthcare sector after having spent more than 20 years within the industry. Prior to joining Mölnlycke, he was President and CEO of Sweden-based CellaVision, a world-leading provider of digital solutions for medical microscopy in the field of hematology, listed on Nasdaq Nordic.
Previous positions include EVP Sales & Marketing at ORIGIO, as well as President GBU Chronic at Gambro and Director Patient Handling Product Division at ArjoHuntleigh.
CONTACT:
For more information, please contact:
Jenny Johansson
Global Director Corporate Communications
+46 317 223 423 or jenny.johansson@molnlycke.com
This information was brought to you by Cision http://news.cision.com
The following files are available for download:
|
Release |
|
|
Zlatko Rihter |
View original content:http://www.prnewswire.com/news-releases/zlatko-rihter-assumes-position-as-president-and-ceo-of-molnlycke-301181459.html
SOURCE Mölnlycke
